Suchergebnisse - "Murphy, Sean"

PubPharm (31)

1

Economic Cost of the HealthCall Smartphone Intervention to Reduce Heavy Alcohol Drinking in Adults With HIV

enthalten in: Journal of studies on alcohol and drugs | 2023

von Starbird, L. | Gutkind, S. | Teixeira, P. | +5

2

Collaborative care programs for pregnant and postpartum individuals with opioid use disorder : Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study

enthalten in: Journal of substance use and addiction treatment | 2023

von Kropp, F. | Smid, M. | Lofwall, M. | +5

3

Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration

enthalten in: Addiction science & clinical practice | 2023

von Cadet, T. | Jalali, A. | Jeng, P. | +3

4

Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS) : A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs

enthalten in: Contemporary clinical trials | 2023

von Sung, M. | Viera, A. | Esserman, D. | +16

5

Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release

enthalten in: Journal of substance abuse treatment | 2022

von Jalali, A. | Jeng, P. | Polsky, D. | +4

6

Randomized controlled trial of Regulation Focused Psychotherapy for children : A manualized psychodynamic treatment for externalizing behaviors

enthalten in: Psychotherapy research : journal of the Society for Psychotherapy Research | 2022

von Prout, T. | Rice, T. | Chung, H. | +3

7

Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk : Design and rationale

enthalten in: Contemporary clinical trials | 2022

von Perez-Correa, A. | Abbas, B. | Riback, L. | +7

8

Brief Report : No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Shaffer, D. | Kumwenda, J. | Chen, H. | +12

9

Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder : a secondary analysis

enthalten in: Addiction (Abingdon, England) | 2021

von Murphy, S. | Jeng, P. | McCollister, K. | +8

10

Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Kublin, J. | Murphy, S. | Maenza, J. | +16